Results 41 to 50 of about 2,517 (166)
Veterinary Medicine and Science, Volume 12, Issue 5, September 2026.High seroprevalence of Rift Valley fever virus antibodies (47.9%) in small ruminants in Maiduguri indicates substantial past exposure. Age, sex, and residence in flood‐prone areas were significant risk factors, highlighting the need for targeted surveillance and vector control to reduce livestock and public health impacts.
Sani Mohammed +8 more
wiley +1 more source
Cell Biochemistry and Function, Volume 44, Issue 8, August 2026.ABSTRACT The impact of Mycoplasma contaminations on in vitro test systems has been extensively discussed and in vitro studies have demonstrated various effects on the physiology of the contaminated cell line. Thus far, little is known about the effect of biologically active substances, such as viruses produced in contaminated cell lines on primary ...
Patricia Gogesch +5 more
wiley +1 more source
LKB1 restricts RVFV infection.
, 2012 A. RVFV was plaqued on LKB1−/−;LKB1 and LKB1−/−;Vec MEFs. Representative data from triplicate experiments is shown. B. Quantification of plaques from A. presented as the normalized mean±SD of wild type plaques from three experiments. C.
Sara Cherry (170695) +2 more
core +1 more source
BMC Infectious Diseases, 2018 Background In the past two decades, Rift Valley Fever (RVF) outbreaks have been reported twice in Tanzania, with the most recent outbreak occurring in 2006/07.
Abade Ahmed +4 more
doaj +1 more source
Advanced Science, Volume 13, Issue 31, 4 June 2026.RNF213 is characterized as a dual‐functional antiviral effector. It directly mediates the degradation of the influenza A virus nucleoprotein (NP) while simultaneously activating the MDA5‐mediated innate immune signaling pathway. This coordinated response establishes a powerful host defense system against viral infection. ABSTRACT Influenza A virus (IAV)
Haoning Li +5 more
wiley +1 more source
AMPK restricts RVFV RNA replication.
, 2012 A. Northern blot of genomic S segment and N mRNA from RVFV (MOI 1) grown in WT or AMPKα1/AMPKα2−/− MEFs for 4, 8, or 12 hours. A representative of triplicate experiments is shown. B–C.
Sara Cherry (170695) +2 more
core +1 more source
Potential entry pathways for 25 vector‐borne disease agents
EFSA Journal, Volume 24, Issue 5, May 2026.Abstract This Scientific Report identifies the potential entry pathways for 25 selected vector‐borne diseases (VBDs) into currently free EU Member States. The diseases comprise 12 listed under the Animal Health Law (AHL) and 13 non‐listed diseases, selected using predefined eligibility criteria.
European Food Safety Authority (EFSA) +7 more
wiley +1 more source
, 2018 Distribution of RVFV IgM seropositivity and neutralizing RVFV antibodies in Kyela and Morogoro districts, Tanzania.
Linda Peniel Salekwa (5954165) +5 more
core +1 more source
Knowledge mapping of risk mitigation measures against vector‐borne diseases
EFSA Journal, Volume 24, Issue 5, May 2026.Abstract A comprehensive synthesis of current evidence on surveillance, prevention and control measures for 25 selected vector‐borne diseases (VBDs) affecting animals in the EU is presented here. The assessment integrates evidence from systematic literature reviews, modelling studies, field investigations and expert judgement.
European Food Safety Authority (EFSA) +8 more
wiley +1 more source
Adaptive cell mediated immunity in RVFV-infected goats.
, 2012 Means of PBMC IFN-γ response from IN-RVFV-infected goats are represented by the open histograms and MAM-RVFV infected goats by the filled histograms. Error bars represent standard deviation of means (n = 4 goats each).
Peter Marszal (169135) +3 more
core +1 more source